UB Paderborn / Katalog / Suche / in CDI

Insulin resistance and need for a lifestyle change to eliminate it

Bratislavské lékarské listy, 2021-01, Vol.122 (8), p.567-571

2021

Volltextzugriff (PDF)

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings

International journal of clinical practice (Esher), 2012-11, Vol.66 (11), p.1033-1041

2012

Volltextzugriff (PDF)

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

The New England journal of medicine, 2012-12, Vol.367 (23), p.2204-2213

2012

Volltextzugriff (PDF)

P104 Insulin pump therapy and metabolic goals in pregnancies complicated by type 1 diabetes mellitus

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S440-S440

2009

Volltextzugriff (PDF)

PDB79 - Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

Value in health, 2014-11, Vol.17 (7), p.A345-A346

2014

Volltextzugriff (PDF)

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings: Low risk of severe hypoglycaemia with premixed insulin analogues

International journal of clinical practice (Esher), 2012-11, Vol.66 (11), p.1033-1041

2012

Volltextzugriff (PDF)

An international, multicenter, observational survey to evaluate diabetes control in subjects using insulin for the treatment of type 1 and type 2 diabetes mellitus in the Czech Republic and Slovak Republic: study protocol for a cross-sectional survey

Open access journal of clinical trials, 2016-01, Vol.8 (Issue 1), p.13-20

2016

Volltextzugriff (PDF)

Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses

Medical hypotheses, 1997-09, Vol.49 (3), p.271-275

1997

Volltextzugriff (PDF)

Digoxin-like immunoactivity in pregnant women with diabetes mellitus

American journal of hypertension, 1996-05, Vol.9 (5), p.516-516

1996

Volltextzugriff (PDF)

Endogenous digitalis-like substance. II. Relation to pathologic states and diseases

Vnitřní lékar̆stvĭ, 1995-10, Vol.41 (10), p.719

Martinka, E

1995

Volltextzugriff (PDF)

Endogenous digitalis-like substance. I. Basic characteristics

Vnitřní lékar̆stvĭ, 1995-09, Vol.41 (9), p.637

Martinka, E

1995

Volltextzugriff (PDF)

ENDOTHELIAL MARKERS IN DIABETES MELLITUS

Thrombosis research, 1997, Vol.85 (1), p.63-65

1997

Volltextzugriff (PDF)

Epidemiological characteristics of diabetes mellitus in Slovakia, 1992-2002

Epidemiologie, mikrobiologie, imunologie, 2006-04, Vol.55 (2), p.68

2006

Volltextzugriff (PDF)

Insulin antibodies in patients with type 2 diabetes mellitus

Vnitřní lékar̆stvĭ, 1998-10, Vol.44 (10), p.577

1998

Volltextzugriff (PDF)

Association of type I diabetes mellitus with HLA alleles

Bratislavské lékarské listy, 2000, Vol.101 (11), p.624-625

2000

Volltextzugriff (PDF)

Endogenous Digoxin-like Immunoactivity in Subjects With Diabetes Mellitus and Hypertension

American journal of hypertension, 1998-06, Vol.11 (6), p.667-676

1998

Volltextzugriff (PDF)

Insulin Treatment Inhibits PAI-1 Production in NIDDM Patients with Endothelial Dysfunction

Clinical and applied thrombosis/hemostasis, 1998-10, Vol.4 (4), p.250-252

1998

Volltextzugriff (PDF)

Latent autoimmune (type 1) diabetes mellitus in patients originally classified as type 2. Divergence of etiologic markers

Časopis lékařů českých, 2000-03, Vol.139 (4), p.120

2000

Volltextzugriff (PDF)

Plasminogen Activator Inhibitor Type-1 (PAI-1) Levels Are Decreased in NIDDM Patients treated with Insulin

Clinical and applied thrombosis/hemostasis, 1998-04, Vol.4 (2), p.138-139

1998

Volltextzugriff (PDF)

Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A

Vnitřní lékar̆stvĭ, 1999-02, Vol.45 (2), p.97

1999

Volltextzugriff (PDF)

Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases

Vnitřní lékar̆stvĭ, 1999-02, Vol.45 (2), p.103

1999

Volltextzugriff (PDF)

Tissue plasminogen activator and diabetes mellitus

Vnitřní lékar̆stvĭ, 1998-11, Vol.44 (11), p.661

1998

Volltextzugriff (PDF)

Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (part II)

Vnitřní lékar̆stvĭ, 1996-03, Vol.42 (3), p.200

1996

Volltextzugriff (PDF)

Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (I)

Vnitřní lékar̆stvĭ, 1996-01, Vol.42 (1), p.31

1996

Volltextzugriff (PDF)

Scleredema diabeticorum in a patient with latent autoimmune diabetes in adults (LADA)

EJD. European journal of dermatology, 1997-12, Vol.7 (8), p.596-598

1997

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Insulin resistance and need for a lifestyle change to eliminate it

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings

Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes

P104 Insulin pump therapy and metabolic goals in pregnancies complicated by type 1 diabetes mellitus

PDB79 - Health-Economic Comparison of Sensor-Augmented Pump With Low Glucose Suspend Versus Insulin Pump Alone For The Treatment Of Hypo-Prone Type 1 Diabetes In Slovakia

Low risk of severe hypoglycaemia in patients with type 2 diabetes mellitus starting insulin therapy with premixed insulin analogues BID in outpatient settings: Low risk of severe hypoglycaemia with premixed insulin analogues

An international, multicenter, observational survey to evaluate diabetes control in subjects using insulin for the treatment of type 1 and type 2 diabetes mellitus in the Czech Republic and Slovak Republic: study protocol for a cross-sectional survey

Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses

Digoxin-like immunoactivity in pregnant women with diabetes mellitus

Endogenous digitalis-like substance. II. Relation to pathologic states and diseases

Endogenous digitalis-like substance. I. Basic characteristics

ENDOTHELIAL MARKERS IN DIABETES MELLITUS

Epidemiological characteristics of diabetes mellitus in Slovakia, 1992-2002

Insulin antibodies in patients with type 2 diabetes mellitus

Association of type I diabetes mellitus with HLA alleles

Endogenous Digoxin-like Immunoactivity in Subjects With Diabetes Mellitus and Hypertension

Insulin Treatment Inhibits PAI-1 Production in NIDDM Patients with Endothelial Dysfunction

Latent autoimmune (type 1) diabetes mellitus in patients originally classified as type 2. Divergence of etiologic markers

Plasminogen Activator Inhibitor Type-1 (PAI-1) Levels Are Decreased in NIDDM Patients treated with Insulin

Latent autoimmune (Type-1) diabetes mellitus in adults. Part. I. Serologic markers of autoimmune involvement of pancreatic beta-cells: GADA, ICA, IA-2 a IA-A

Latent autoimmune (type I) diabetes mellitus in adults. Part. II. Association of HLA antigens, status of cellular immunity and occurrence of other autoimmune diseases

Tissue plasminogen activator and diabetes mellitus

Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (part II)

Insulin resistance and pathogenesis of non-insulin-dependent diabetes mellitus (I)

Scleredema diabeticorum in a patient with latent autoimmune diabetes in adults (LADA)

Suchergebnisse filtern